HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Human, P. Articles by Zilla, P. Search for Related Content PubMed PubMed Citation Articles by Human, P. Articles by Zilla, P. Related Collections Molecular biology Valve disease

Ann Thorac Surg 2001;71:S385-S388
© 2001 The Society of Thoracic Surgeons

---

Basic research

Characterization of the immune response to valve bioprostheses and its role in primary tissue failure

^a Department of Cardiothoracic Surgery, Cape Heart Centre, University of Cape Town Medical School, Cape Town, South Africa

Address reprint requests to Mr Human, Cardiovascular Research Unit, Cape Heart Centre, Faculty of Health Sciences, University of Cape Town, Anzio Rd, 7925 Observatory, Cape Town, South Africa
e-mail: ctshuman{at}samiot.uct.ac.za

Presented at the VIII International Symposium on Cardiac Bioprostheses, Cancun, Mexico, Nov 3–5, 2000.

Background. The role of an immune response in the failure of bioprosthetic heart valves is poorly understood and disregarded by many. To elucidate the nature of the immune response to glutaraldehyde-treated tissue and the possible role of graft-specific antibody in graft mineralization, we performed immune-calcification studies in the rabbit and correlated those results with the analysis of specific antibodies.

Methods. Aortic wall buttons (6 mm) were punched from porcine aortic wall tissue fixed with 0.2% glutaraldehyde and detoxified with urazole and then subsequently perforated under sterile conditions. The perforated buttons were then incubated with either immune serum prepared by immunization of New Zealand White rabbits (n = 5) with Freund’s incomplete adjuvant emulsions of tissue homogenates of similarly treated aortic wall tissue, or incubated with the corresponding control preimmune sera obtained before immunization of the same animals. The tissue was then implanted subdermally on the back of unrelated New Zealand White rabbits (n = 8) for a period of 3 weeks. After the buttons were explanted, tissue calcium levels were determined by atomic absorption spectroscopy.

Results. Tissue calcium was increased in all five immune serum-treated replicates (range, 61.8% to 431.2%; mean, 225.9% ± 73.2%) when compared with control samples treated with preimmune sera. Overall, the mean calcium level was significantly increased (p < 0.0001) when tissue was treated with immune sera (66.0 ± 10.0 µg/mg versus 22.6 ± 4.8 µg/mg in control tissue). Graft specificity of immune sera was confirmed by Western blot analysis.

Conclusions. These results strongly suggest a role of circulating graft-specific antibody in the disease of bioprosthetic graft calcification.

This article has been cited by other articles:

				G. Van Nooten, P. Somers, M. Cornelissen, S. Bouchez, F. Gasthuys, E. Cox, L. Sparks, and K. Narine Acellular porcine and kangaroo aortic valve scaffolds show more intense immune-mediated calcification than cross-linked Toronto SPV(R) valves in the sheep model Interactive CardioVascular and Thoracic Surgery, October 1, 2006; 5(5): 544 - 549. [Abstract] [Full Text] [PDF]

				R. A. Manji, L. F. Zhu, N. K. Nijjar, D. C. Rayner, G. S. Korbutt, T. A. Churchill, R. V. Rajotte, A. Koshal, and D. B. Ross Glutaraldehyde-Fixed Bioprosthetic Heart Valve Conduits Calcify and Fail From Xenograft Rejection Circulation, July 25, 2006; 114(4): 318 - 327. [Abstract] [Full Text] [PDF]

				E. Rieder, G. Seebacher, M.-T. Kasimir, E. Eichmair, B. Winter, B. Dekan, E. Wolner, P. Simon, and G. Weigel Tissue Engineering of Heart Valves: Decellularized Porcine and Human Valve Scaffolds Differ Importantly in Residual Potential to Attract Monocytic Cells Circulation, May 31, 2005; 111(21): 2792 - 2797. [Abstract] [Full Text] [PDF]

				T. E. David and J. Ivanov Is degenerative calcification of the native aortic valve similar to calcification of bioprosthetic heart valves? J. Thorac. Cardiovasc. Surg., October 1, 2003; 126(4): 939 - 941. [Full Text] [PDF]

				A. Trantina-Yates, C. Weissenstein, P. Human, and P. Zilla Stentless bioprosthetic heart valve research: sheep versus primate model Ann. Thorac. Surg., May 1, 2001; 71 (2007): S422 - S427. [Abstract] [Full Text] [PDF]